Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 6/20 | 0.59 |
| ▸ | MEN1 | O00255 | 6/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.58 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.55 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.55 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.51 |
| ▸ | CRHBP | P24387 | 1/20 | 0.51 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11150669 | 1.00 | MAPT (0.59) | MAPTMEN1KMT2AMAPK1TDP1 | |
| SCHEMBL16140 | 0.98 | MAPT (0.61) | MAPTMEN1KMT2AMAPK1TDP1 | |
| SCHEMBL29352891 | 0.98 | MAPT (0.61) | MAPTMEN1KMT2AMAPK1TDP1 | |
| SCHEMBL27470180 | 0.98 | MAPT (0.61) | MAPTMEN1KMT2AMAPK1TDP1 | |
| SCHEMBL28247841 | 0.98 | MAPT (0.61) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Water SCHEMBL9233283 | 0.96 | MAPT (0.59) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Methane SCHEMBL28068825 | 0.96 | MAPT (0.59) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Formaldehyde SCHEMBL28414752 | 0.95 | MAPT (0.58) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Methyl Alcohol SCHEMBL27980452 | 0.93 | MAPT (0.56) | MAPTMEN1KMT2AMAPK1TDP1 | |
| Phosphoric Acid SCHEMBL30231818 | 0.90 | MAPT (0.54) | MAPTMEN1KMT2AMAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116804661-A | Method for measuring formaldehyde content in antiviral drug of lovir raw material drug by HPLC | 湖北省宏源药业科技股份有限公司 | 2023-09-26 | — | — | CN | claimed |
| CN-113281421-A | Efficient determination method for formaldehyde in starch food | 贵州省产品质量检验检测院 | 2021-08-20 | — | — | CN | claimed |
| CN-111693632-A | Method for extracting total formaldehyde in cosmetics and rapid detection method | 上海市食品药品检验所 | 2020-09-22 | — | — | CN | claimed |
| CN-108828089-A | The method that derivatization HPLC-UV/Vis method measures 4- nitrobenzaldehyde in chloramphenicol or its preparation | 中国药科大学 | 2018-11-16 | — | — | CN | claimed |
| EP-4443155-B1 | ENCAPSULATED PRE-ANALYTIC WORKFLOWS FOR FLOW-THROUGH DEVICES, LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC ANALYSIS | WATERS TECHNOLOGIES CORP (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12616220-B2 | Method for producing plant-based milk-fermented liquid | ASAHI GROUP HOLDINGS, LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| US-12487210-B2 | Encapsulated pre-analytic workflows for flow-through devices, liquid chromatography and mass spectrometric analysis | WATERS TECHNOLOGIES CORPORATION (US) | 2025-12-02 | — | — | US | disclosed |
| EP-4443155-A2 | ENCAPSULATED PRE-ANALYTIC WORKFLOWS FOR FLOW-THROUGH DEVICES, LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC ANALYSIS | Waters Technologies Corporation (US) | 2024-10-09 | — | — | EP | disclosed |
| EP-3491374-B1 | ENCAPSULATED PRE-ANALYTIC WORKFLOW REAGENTS FOR FLOW-THROUGH DEVICES, LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC ANALYSIS | WATERS TECHNOLOGIES CORP (US) | 2024-10-09 | — | — | EP | disclosed |
| WO-2024162063-A1 | AQUEOUS DISPERSION AND RESIN FILM FORMED FROM SAID AQUEOUS DISPERSION | 住友化学株式会社 | 2024-08-08 | — | — | WO | disclosed |
| US-20240172780-A1 | METHOD FOR PRODUCING PLANT-BASED MILK-FERMENTED LIQUID | ASAHI GROUP HOLDINGS, LTD. (JP) | 2024-05-30 | — | — | US | disclosed |
| US-20240172767-A1 | METHOD FOR PRODUCING PLANT-BASED MILK-FERMENTED LIQUID | ASAHI GROUP HOLDINGS, LTD. (JP) | 2024-05-30 | — | — | US | disclosed |
| US-5512466-A | EXPRESSION OF A 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID METABOLIZING ENZYME TO INHIBIT PRODUCTION OF ETHYLENE | MONSANTO COMPANY (US) | 1996-04-30 | — | — | US | disclosed |
| US-5300497-A | Broad spectrum antibiotics and bactericides; stable to beta-lactamase; effective against antibiotic-resistant bacteria | TOYAMA CHEMICAL CO., LTD. (JP) | 1994-04-05 | — | — | US | disclosed |
| EP-0564524-A1 | CONTROL OF FRUIT RIPENING AND SENESCENCE IN PLANTS | MONSANTO COMPANY (US) | 1993-10-13 | — | — | EP | disclosed |
| US-5185330-A | Penicillins/ad/ | TOYAMA CHEMICAL CO., LTD. (JP) | 1993-02-09 | — | — | US | disclosed |
| WO-1992012249-A1 | CONTROL OF FRUIT RIPENING AND SENESCENCE IN PLANTS | MONSANTO COMPANY (US) | 1992-07-23 | — | — | WO | disclosed |
| EP-0010615-B1 | METHOD AND REAGENT FOR DETERMINING IONS, POLAR AND/OR LIPOPHILIC COMPOUNDS IN LIQUIDS | Roche Diagnostics GmbH (DE) | 1984-07-25 | — | — | EP | disclosed |
| US-4367072-A | Ligands assayed by host molecules including cyclophanes, crown ethers, crypstands and podands | BOEHRINGER MANNHEIM GMBH (DE) | 1983-01-04 | — | — | US | disclosed |
| US-3950427-A | ANTIINFLAMMATORY, ANTIPYRETIC | BOEHRINGER INGELHEIM GMBH (DT) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616220-B2 | Method for producing plant-based milk-fermented liquid | LPO, LCT, CA9 | GAA 290/4885MAPT 711/4885MEN1 3797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.